Efficacy results from the ToGA trial: a phase III study of trastuzumab added to standard chemotherapy in first-line HER2-positive advanced gastric cancer. Proc ASCO 2009: Suppl-Abstr LBA4509 - Van Cutsem, E; Kang, Y; Chung, H; Shen, L